共 198 条
[11]
Clark C.M.(2007)Cerebrospinal fluid-amyloid 1–42 concentration may predict cognitive decline in older women J Neurol Neurosurg Psychiatry 78 461-464
[12]
Farlow M.R.(2007)Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy controls Dement Geriatr Cogn Disord 24 118-124
[13]
Decarli C.(2008)Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease Alzheimers Dement 4 38-48
[14]
Chabal C.(2006)CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer’s disease Brain 129 3035-3041
[15]
Vavrek D.(2003)CSF A 42 levels correlate with amyloid-neuropathology in a polpulation-based autopsy study Neurology 60 652-656
[16]
Raskind M.A.(2006)Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 512-519
[17]
Galasko D.(2001)Differential increase in cerebrospinal fluid-acetylcholine esterase after treatment with acetylcholine esterase inhibitors in patients with Alzheimer’s disease Neurosci Lett 300 157-160
[18]
Andreasen N.(2002)Cerebrospinal fluid levels of biomarkers and activity of acetyl cholinesterase and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors Neurol Sci 23 S95-S96
[19]
Minthon L.(2007)Longitudinal stability of CSF biomarkers in Alzheimer’s disease Neurosci Lett 419 18-22
[20]
Davidsson P.(2007)Intra-Individual Stability of CSF Biomarkers for Alzheimer’s Disease over Two Years J Alzheimers Dis 12 255-260